Cancer immunotherapy clinical trial shows promise, but dangers remain
A novel form of cancer immunotherapy has shown exceptional promise in a new clinical trial. The treatment involves supercharging a patient’s immune cells to fight cancer then reintroducing them to the body, and as many as 93 percent of participants in … Continue reading Cancer immunotherapy clinical trial shows promise, but dangers remain